Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion (original) (raw)

Abstract

MN/CA IX is a cell surface protein, strongly associated with several types of human carcinomas. It exerts activity of carbonic anhydrase and capacity of binding to cell surface receptors. In the present work, we used affinity purified MN/CA IX protein to demonstrate that the cells adhere to immobilized MN/CA IX and that the monoclonal antibody M75 abrogates cell attachment to MN/CA IX. Using synthetic oligopeptides, we identified M75 epitope and located it in the proteoglycan domain, which contains a sixfold tandem repeat of six amino acids GEEDLP. From phage display library of random heptapeptides we identified and chemically synthesized those which compete for the epitope with M75 and inhibit adhesion of cells to MN/CA IX. These heptapeptides might serve as lead compounds for drug design. © 2000 Cancer Research Campaign

Keywords: cell adhesion molecules, carbonic anhydrase, tumour immunology, phage display, drug design

Full Text

The Full Text of this article is available as a PDF (270.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Falkbring S. O., Göthe P. O., Nyman P. O., Sundberg L., Porath J. Affinity chromatography of carbonic anhydrase. FEBS Lett. 1972 Aug 1;24(2):229–235. doi: 10.1016/0014-5793(72)80773-7. [DOI] [PubMed] [Google Scholar]
  2. Liao S. Y., Aurelio O. N., Jan K., Zavada J., Stanbridge E. J. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 1997 Jul 15;57(14):2827–2831. [PubMed] [Google Scholar]
  3. Liao S. Y., Brewer C., Závada J., Pastorek J., Pastorekova S., Manetta A., Berman M. L., DiSaia P. J., Stanbridge E. J. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol. 1994 Sep;145(3):598–609. [PMC free article] [PubMed] [Google Scholar]
  4. Oosterwijk E., Ruiter D. J., Hoedemaeker P. J., Pauwels E. K., Jonas U., Zwartendijk J., Warnaar S. O. Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer. 1986 Oct 15;38(4):489–494. doi: 10.1002/ijc.2910380406. [DOI] [PubMed] [Google Scholar]
  5. Opavský R., Pastoreková S., Zelník V., Gibadulinová A., Stanbridge E. J., Závada J., Kettmann R., Pastorek J. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics. 1996 May 1;33(3):480–487. doi: 10.1006/geno.1996.0223. [DOI] [PubMed] [Google Scholar]
  6. Pastorek J., Pastoreková S., Callebaut I., Mornon J. P., Zelník V., Opavský R., Zat'ovicová M., Liao S., Portetelle D., Stanbridge E. J. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 1994 Oct;9(10):2877–2888. [PubMed] [Google Scholar]
  7. Pastoreková S., Závadová Z., Kostál M., Babusíková O., Závada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology. 1992 Apr;187(2):620–626. doi: 10.1016/0042-6822(92)90464-z. [DOI] [PubMed] [Google Scholar]
  8. Pierschbacher M. D., Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A. 1984 Oct;81(19):5985–5988. doi: 10.1073/pnas.81.19.5985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Saarnio J., Parkkila S., Parkkila A. K., Haukipuro K., Pastoreková S., Pastorek J., Kairaluoma M. I., Karttunen T. J. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol. 1998 Jul;153(1):279–285. doi: 10.1016/S0002-9440(10)65569-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Saarnio J., Parkkila S., Parkkila A. K., Waheed A., Casey M. C., Zhou X. Y., Pastoreková S., Pastorek J., Karttunen T., Haukipuro K. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem. 1998 Apr;46(4):497–504. doi: 10.1177/002215549804600409. [DOI] [PubMed] [Google Scholar]
  11. Steffens M. G., Boerman O. C., Oosterwijk-Wakka J. C., Oosterhof G. O., Witjes J. A., Koenders E. B., Oyen W. J., Buijs W. C., Debruyne F. M., Corstens F. H. Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. J Clin Oncol. 1997 Apr;15(4):1529–1537. doi: 10.1200/JCO.1997.15.4.1529. [DOI] [PubMed] [Google Scholar]
  12. Turner J. R., Odze R. D., Crum C. P., Resnick M. B. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker. Hum Pathol. 1997 Jun;28(6):740–744. doi: 10.1016/s0046-8177(97)90185-4. [DOI] [PubMed] [Google Scholar]
  13. Vermylen P., Roufosse C., Burny A., Verhest A., Bosschaerts T., Pastorekova S., Ninane V., Sculier J. P. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J. 1999 Oct;14(4):806–811. doi: 10.1034/j.1399-3003.1999.14d14.x. [DOI] [PubMed] [Google Scholar]
  14. Závada J., Závadová Z., Pastoreková S., Ciampor F., Pastorek J., Zelník V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer. 1993 May 8;54(2):268–274. doi: 10.1002/ijc.2910540218. [DOI] [PubMed] [Google Scholar]